However, SIRT2 is also defined as an oncogenic factor associated with cell proliferation and shortened overall survival in pancreatic cancer, hepatocellular carcinoma (HCC), and neuroblastoma [36,38,42]. The gene discussed is SIRT2; the disease is hepatocellular carcinoma.